# TIF / TKO Market-Readiness Strategy

**Date:** 2026-07-23  
**Scope:** TKO public site, TIF repository capability, live production experience, public LinkedIn profile, search/indexing readiness, content architecture, conversion, and measurement  
**Operating decision:** This report does not change site positioning, information architecture, production configuration, or TIF/RachelOS behavior.

## 1. Executive diagnosis

### The central finding

Two different things are being discussed as though they are one:

- **TIF** is the internal multichannel content production mechanism. Its intended job is to turn admitted evidence into useful site assets—use cases, scenarios, guides, white papers, evidence pages, and related resources—then generate channel-specific LinkedIn, Instagram, and Facebook packages that link back to the appropriate canonical site asset. Today it can persist Evidence → Opportunity → Asset → Version → Derivative and support human review. It is not yet a proven publishing, authentic-voice, or revenue-attribution system.
- **TKO Solutions** is the market-facing business. The current public offer is a $25,000, 15-business-day **Prior Authorization Performance Diagnostic**, followed when warranted by a $65,000–$95,000 **90-Day Prior Authorization Improvement Sprint**.

The smallest credible market strategy is therefore:

> Sell Todd’s principal-led prior-authorization expertise through one repeatable Diagnostic. Use TIF behind the scenes to create one evidence-backed canonical site asset and adapt it into genuinely different LinkedIn, Instagram, and Facebook packages. Todd reviews and publishes every item manually. Do not market TIF as the product or claim that pipeline and closed deals prove TIF caused revenue until source-to-asset-to-opportunity lineage exists.

### Commercial urgency and strategic consequence

Todd remains employed by Cognizant and currently works on a UnitedHealthcare project. The family also has a near-term need for additional income, including college costs next year.

That makes **employment protection and revenue focus equally important**:

- Do not name UnitedHealthcare, describe its project, imply endorsement, reuse project language, publish observations learned through the engagement, or use any client artifact, metric, scenario, screenshot, or internal problem as content without explicit written authorization from the appropriate parties.
- Confirm Cognizant’s outside-business, conflict-of-interest, invention-assignment, confidentiality, social-media, and client non-solicitation rules before Todd publicly offers overlapping paid work.
- Build initial content from Todd’s approved career knowledge, public sources, founder-built systems, generic illustrative scenarios, and independently developed TKO methods.
- Optimize the first 90 days for warm conversations and referrals supported by content. SEO and social reach are compounding assets, but they are unlikely to solve next year’s income requirement by themselves.

### What the site offers today

The live site presents a senior-led provider-side prior-authorization advisory offer for specialty medical groups, MSOs, and other healthcare operators. It promises a measured baseline, workflow and exception map, root-cause analysis, target workflow, and 90-day plan—not software, staffing, clinical review, or guaranteed outcomes.

### Why a buyer might choose it

- One bounded starting engagement with price, duration, inputs, outputs, exclusions, and decision criteria.
- Todd’s verified operating background across regulated operations, product, healthcare interoperability, healthcare transformation, and implementation.
- A defensible point of view: stabilize and measure the workflow before funding more automation.
- Principal-led delivery instead of a junior assessment team.
- Honest claim boundaries and no invented savings or denial-reduction claims.

### What remains unconvincing

- The public proof supports experience, mechanisms, and build capability—not attributable prior-authorization outcomes.
- The site spends too much space explaining what its evidence does **not** prove. Honesty builds trust; repetition makes the argument feel defensive.
- The founder has no visible headshot or concise personal narrative above the career record.
- The contact form asks for substantial qualification before the visitor has had a conversation.
- The live public LinkedIn profile remains broader than the site’s position. Its visible Services categories span IT consulting, SaaS development, executive coaching, project/program management, and other broad work. The public website link resolves through LinkedIn to an unrelated domain rather than TKO.
- No durable analytics provider, verified Search Console evidence, or observable source-to-pipeline attribution was found.

### Launch verdict

**The site is technically crawlable and materially clearer than older audits, but the go-to-market system is not yet ready to be called measured or proven.**

Launch should be treated as a controlled commercial validation, not a scaled content program. The first goal is not traffic volume. It is to generate and learn from qualified conversations with the right provider-side buyers.

---

## 2. Audit basis

### Evidence-based findings

- Production `https://tko.solutions/` returns 200 and is server-rendered.
- `robots.txt` returns 200, allows public crawling, disallows `/tif`, and references the sitemap.
- `sitemap.xml` returns 200 and lists 19 public URLs.
- Core public routes return 200; retired `/about`, `/case-studies`, and `/offers` routes return permanent redirects; a nonexistent route returns 404.
- Public routes have distinct titles, descriptions, H1s, and canonicals in source.
- `/tif` routes are excluded from crawling and their pages are marked `noindex, nofollow`.
- Organization, Person, Service, Offer, Article, and FAQ structured data are present where applicable.
- The homepage, navigation, contact page, and mobile menu rendered successfully in the live browser.
- The main public content is available without client-side JavaScript.
- The repository has a provider-neutral conversion-event contract, but no connected analytics destination was found in production HTML.
- Form submissions persist to `InboundLead`; repeated submissions upsert by email.
- Lead notification failures are returned as a status by `notifyLead`, but the form action does not inspect that status. A lead can therefore persist and the visitor can see success even if Todd receives no email notification.
- The form has accessible labels, required-state semantics, a PHI/confidential-data warning, and a consent checkbox.
- No public privacy-policy route or link was found.
- The mobile menu exposes an accessible name, expanded state, Escape handling, and scroll locking. It does not implement focus containment or explicit focus return.
- No skip-to-content link was found.
- All 86 tests passed and lint passed on 2026-07-23.
- The production build initially failed only because the sandbox prohibited an internal compiler port; the approved rerun completed successfully, generating 27 static pages/routes with 121 kB route first-load JavaScript on the core public pages.
- A current public LinkedIn view showed approximately 4K followers and 500+ connections, a broad About opening, broad Services categories, older content across lending, PE, wealth, real estate, and AI, and no clearly visible prior-authorization specialization in the public top-card text.
- A search-engine spot check did not surface TKO pages for `site:tko.solutions` or the exact Diagnostic name. This is a spot check, not an index-coverage report.

### Reasonable inferences

- The current site is likely stronger as a referral-validation asset than as a near-term organic acquisition engine.
- A $25,000 first engagement will require stronger human trust and outcome-adjacent proof than the site currently provides.
- The broad LinkedIn history will cause some visitors to interpret Todd as a general AI/product/operations consultant unless the profile and next 8–12 posts narrow the signal.
- Provider-side prior-authorization software vendors are not exact competitors, but they are the most common alternative frame. TKO must explain why independent workflow diagnosis precedes vendor selection.
- The long contact form will improve lead qualification but reduce total starts and completions. Without analytics, the tradeoff cannot be evaluated.
- The five insight articles are substantive, but four repeat the same “workflow before automation / hidden judgment / Human API” thesis. More articles on the same argument would create diminishing value and potential topic overlap.

### Information still needed

1. Written confirmation that Todd can publicly market TKO while employed by Cognizant, including conflict-of-interest, IP, client-reference, and social-media constraints.
2. The intended meaning of “make TIF ready for market”: internal GTM production system or externally sold product. This report recommends the former.
3. Search Console and analytics access or exports.
4. Whether the production database and Resend notification environment are configured and monitored.
5. A TKO-domain email address and scheduling link, if approved.
6. A publishable headshot.
7. The exact natural-voice preference for Todd: concise/operator, contrarian, technical, or executive-advisory.
8. Anonymized pipeline and closed-deal evidence with dates, source fields, touched assets, permissions, and confounders.
9. Any publishable PA engagement artifact, client quote, reference, baseline, or post-change measure.
10. Desired launch date and weekly time available for publishing and relationship work.

---

## 3. Prioritized audit

| Priority | Severity | Area | Evidence | Recommended fix | Expected effect | Effort | Dependencies |
|---|---|---|---|---|---|---|---|
| P0 | Critical | Employment / compliance | Todd is employed by Cognizant and currently works on a UnitedHealthcare project while TKO targets an overlapping healthcare workflow category. | Obtain written clarity on outside work, conflicts, IP, confidentiality, social activity, non-solicitation, and permitted positioning. Establish a strict current-client content firewall. | Protects the primary income source and prevents client/employer misuse. | Low | Todd, Cognizant policy/approval, counsel if needed |
| P0 | Critical | Positioning | TIF is noindex internal software; TKO is the public PA offer. TIF itself lacks publishing and attribution. | Ratify TIF as the internal evidence/asset system and TKO as the market offer. Do not add a public TIF product page. | Prevents a second, unsupported category story. | Low | Owner decision |
| P0 | Critical | Operations / conversion | Notification failure can be silently treated as success after persistence. | Add notification monitoring and a daily lead-reconciliation check; later make notification state visible to the operator without exposing errors to the visitor. | Prevents lost qualified inquiries. | Low | Production env access |
| P0 | Critical | Measurement | Event abstraction exists, but no durable analytics destination or GSC evidence was found. | Connect a privacy-reviewed analytics provider, verify GSC/Bing, submit sitemap, and test events. | Makes launch learnable. | Medium | Account/domain authority |
| P0 | High | LinkedIn / positioning | Public profile and Services remain broad; visible site link is unrelated to TKO. | Update website, headline, About, banner, Services, and Featured items around the PA offer. | Aligns the strongest existing audience asset with the offer. | Low | Todd access; employer approval |
| P0 | High | Trust / compliance | Form collects business personal data; no public privacy notice was found. | Publish a plain-language privacy notice covering purpose, fields, processors, retention, deletion/contact, and no-PHI rule. | Reduces legal and trust risk. | Low | Counsel/owner review |
| P0 | High | Proof | Public cases establish experience and mechanism, not attributable PA outcomes. | Create one permissioned proof package: artifact excerpt, role, mechanism, evidence boundary, and—only if defensible—baseline/post-change measures. | Supports a $25K buying decision. | Medium | Evidence and permission |
| P0 | High | Conversion | Primary CTA implies a call, but routes to a long qualification form; no direct booking option is configured. | Keep the fit-call framing but shorten first contact to 5–7 fields or use a two-step flow. Offer scheduling only after fit or as an approved secondary path. | Reduces form abandonment without inviting unqualified calendar load. | Medium | Conversion data / owner preference |
| P1 | High | Credibility | Founder page has strong chronology but no headshot and opens with “buyer diligence” language. | Add a professional headshot and a plain-language founder narrative before the diligence record. | Humanizes a principal-led offer. | Low | Approved image |
| P1 | High | Content | Existing articles cluster around one repeated thesis. | Stop adding thesis variants. Publish decision tools, checklists, measurement definitions, and worked examples. | Builds distinct search and sales utility. | Medium | Expert input |
| P1 | High | Attribution | `InboundLead` upserts by email and stores only the latest payload. | For launch, export submissions weekly and preserve first-touch, last-touch, and touched-content fields in a simple CRM/scorecard. Defer schema expansion until usage proves it. | Prevents history loss and enables assisted attribution. | Low | CRM/scorecard owner |
| P1 | Medium | UX / navigation | “Home” is redundant with the logo; “Results” overstates mostly qualitative evidence; Insights is only in the footer. | Use: Diagnostic, How It Works/Healthcare, Evidence, Insights, About, plus CTA. Rename Results to Evidence. | Improves orientation and expectation setting. | Low | IA approval |
| P1 | Medium | Copy | Repeated claim-boundary language dominates several pages. | State the boundary once per proof unit, then lead with buyer relevance, artifact, mechanism, and decision supported. | Preserves honesty while improving persuasion. | Medium | Editorial review |
| P1 | Medium | Technical SEO | Sitemap `lastModified` is hard-coded to one date for every URL. | Source dates from page/article/case metadata or omit when not reliable. | Improves crawl signals; avoids false freshness. | Low | Content model |
| P1 | Medium | Accessibility | No skip link; mobile menu lacks focus containment/return. | Add skip-to-content; return focus to trigger on close; test keyboard sequence and visible focus. | Improves keyboard usability. | Low | Frontend change |
| P1 | Medium | Abuse prevention | Public form shows no honeypot, rate limit, or challenge strategy in the audited path. | Add invisible honeypot and server-side rate limiting; avoid intrusive CAPTCHA unless abuse appears. | Reduces spam and database/notification abuse. | Low–Medium | Hosting/runtime choice |
| P2 | Medium | SEO | No evidence that new pages are indexed or earning impressions. | Use GSC Page Indexing, URL Inspection, Performance, and rendered-page checks before expanding content. | Prevents publishing into an unobserved system. | Low | GSC access |
| P2 | Low | Schema | FAQ schema is valid but Google generally limits FAQ rich results; Organization/Person repeat globally. | Keep valid schema, but do not count FAQ markup as a growth tactic. Add BreadcrumbList only if breadcrumbs become visible. | Avoids schema busywork. | Low | None |
| P2 | Low | Performance | No field CWV or repeatable lab report was available; public pages are mostly server-rendered and visually stable. | Establish a Lighthouse/WebPageTest baseline for Home, Diagnostic, Contact, and RachelOS evidence page; monitor CWV in GSC. | Creates a performance baseline without premature optimization. | Low | Tool access |

---

## 4. Positioning options

### Option A — Expert-led advisor

- **ICP:** COO, VP/Director of Operations, Revenue Cycle, Patient Access, or transformation leader at a specialty group, MSO, or provider organization with an active PA performance problem.
- **Painful problem:** Leadership knows PA is consuming time and causing delay/rework but cannot agree on the operating cause.
- **Desired outcome:** A trusted diagnosis and fundable next decision.
- **Offer:** Todd personally analyzes one workflow and presents the baseline, causes, target state, and 90-day plan.
- **Differentiator:** Cross-functional operator who can connect workflow, policy, evidence, technology, governance, and adoption.
- **Reasons to believe:** Verified career record; PA/UM and interoperability context; principal-led delivery.
- **Likely objections:** “Is this one person enough?” “Where are the client results?” “Why not use our vendor or internal team?”
- **Proof required:** Headshot, precise role history, a sample artifact, references or permissioned evidence, delivery capacity.
- **CTA:** Discuss the workflow with Todd.
- **Positioning statement:** Todd Kovalsky helps provider-side healthcare leaders find and fix the operating causes of prior-authorization delay, rework, denials, and staff dependency.
- **Headline:** Find where prior authorization is losing time and capacity.
- **Subheadline:** Todd leads a 15-business-day diagnostic of one provider-side workflow and gives leadership the baseline, root causes, and 90-day decision plan.
- **30-second explanation:** “I work with specialty groups and MSOs when prior authorization is taking too long, producing avoidable rework, or depending on a few experienced people. I trace one workflow, measure what is actually happening, and show leadership what to standardize, automate, staff, or stop. The first engagement is fixed-fee and takes 15 business days.”

### Option B — Method-led Diagnostic

- **ICP:** Same buyer, especially one preparing a vendor, staffing, centralization, or automation decision.
- **Painful problem:** The organization lacks a shared baseline and is about to spend against competing explanations.
- **Desired outcome:** One defensible operating decision before larger spend.
- **Offer:** Prior Authorization Performance Diagnostic with defined inputs, five phases, nine deliverables, and decision gates.
- **Differentiator:** Independent pre-investment workflow evidence, not a software recommendation.
- **Reasons to believe:** Clear scope, fixed fee, explicit measurement model, no implementation obligation.
- **Likely objections:** “This is expensive for an assessment.” “We already have dashboards.” “Will it produce change or another deck?”
- **Proof required:** Redacted sample scorecard, workflow map, decision-rights map, backlog, and executive brief.
- **CTA:** Review scope and pricing.
- **Positioning statement:** The Prior Authorization Performance Diagnostic gives provider-side leaders the evidence required to fix, fund, automate, stop, or defer the right workflow changes.
- **Headline:** Make the PA investment decision from one fact base.
- **Subheadline:** In 15 business days, measure one workflow, isolate addressable causes, and leave with a 90-day plan.
- **30-second explanation:** “The Diagnostic is for leaders who are deciding whether they need more staff, a vendor, automation, standardization, or a workflow redesign. We establish the baseline and map the work before recommending the intervention. The result is not a broad transformation deck; it is a bounded decision package for one workflow.”

### Option C — Expert + repeatable system (recommended)

- **ICP:** Provider-side specialty groups and MSOs with multi-role or multi-site PA work, an active performance trigger, a named sponsor, and intent to act within 90 days.
- **Painful problem:** Delay, rework, avoidable denials, inconsistent payer handling, and key-person dependency are forcing a decision without trusted evidence.
- **Desired outcome:** A credible baseline, explicit operating causes, and an accountable 90-day improvement path.
- **Offer:** Todd personally applies the Prior Authorization Performance Diagnostic; if the evidence warrants it, TKO can implement one bounded change through the 90-Day Sprint.
- **Differentiator:** Senior cross-functional judgment delivered through a transparent, repeatable method—independent of any platform sale.
- **Reasons to believe:** Verified experience, defined method, inspectable RachelOS control/build evidence, fixed commercial scope, claim restraint.
- **Likely objections:** Limited public PA outcome proof; solo capacity; potential employment/conflict concerns; price; data access.
- **Proof required:** Permissioned work sample, delivery calendar/capacity, privacy/handling statement, client/reference evidence, and future measured pilot results.
- **CTA:** Request a Diagnostic Fit Call.
- **Positioning statement:** TKO helps specialty medical groups and MSOs find the operating causes of prior-authorization delay, denials, rework, and staff dependency through a principal-led 15-business-day Diagnostic.
- **Headline:** Fix the prior-authorization workflow before you fund more automation.
- **Subheadline:** Todd Kovalsky applies a repeatable 15-business-day Diagnostic to one provider-side workflow, giving leadership the baseline, root causes, target workflow, and 90-day plan worth funding.
- **30-second explanation:** “TKO helps provider organizations when prior authorization is expensive but the cause is disputed. Todd leads a fixed-fee 15-day Diagnostic of one workflow, using operating evidence rather than vendor assumptions. Leadership gets a measured baseline, workflow and exception map, root causes, and a 90-day plan. If implementation is justified, TKO can stay for one controlled pilot.”

### Recommendation and tradeoffs

Choose **Option C**. Option A is human and credible but harder to scale or refer consistently. Option B is concrete but can feel like a packaged consulting worksheet without the senior operator behind it. The combined position explains both why Todd is credible and why the engagement is repeatable.

Do not expose “TIF” as the system buyers purchase. Externally, the repeatable method is the **Prior Authorization Performance Diagnostic**. Internally, TIF supports evidence admission, asset versioning, derivative creation, and claim discipline.

---

## 5. Recommended site and search architecture

### Smallest useful launch set

Keep the current routes to preserve architecture, but make nine URLs the launch-quality core:

1. `/`
2. `/services/diagnostic`
3. `/healthcare`
4. `/selected-work`
5. `/selected-work/prior-authorization-modernization`
6. `/selected-work/from-crm-to-operating-system`
7. `/founder`
8. `/insights/prior-authorization-operational-quality-problem`
9. `/contact`

Keep `/services`, `/services/operating-system-build`, `/insights`, and the remaining evidence/articles indexed, but treat them as secondary. Do not create audience doorway pages by specialty, payer, location, or workflow until each has distinct evidence and a distinct buyer decision job.

### Navigation map

```text
Logo → Home
Diagnostic → /services/diagnostic
How It Works → /healthcare
Evidence → /selected-work
Insights → /insights
About Todd → /founder
Primary CTA → /contact
```

Remove the explicit Home item because the logo provides it. Rename Results to Evidence until attributable results exist.

### Page briefs

#### 1. Homepage — `/`

- **Purpose:** Establish buyer, problem, offer, price/duration, proof, and next step.
- **Reader / intent:** Referred or search-aware provider operations leader; commercial investigation.
- **Primary question:** “Is this specifically for my PA operating problem, and is Todd credible enough to speak with?”
- **Primary topic:** prior authorization workflow improvement.
- **Related terms:** provider-side PA operations, avoidable denials, rework, turnaround, staff dependency, PA automation readiness.
- **Title:** Prior Authorization Workflow Improvement Advisor | TKO Solutions
- **Meta:** TKO helps specialty medical groups and MSOs identify the workflow causes of prior-authorization delay, rework, avoidable denials, and staff dependency in 15 business days.
- **H1:** Fix the prior-authorization workflow before you fund more automation.
- **Outline:** Hero → commercial terms → recognizable trigger → Diagnostic outcome → how the 15 days work → one proof artifact → Todd credibility → good/not fit → CTA.
- **Proof / CTA:** One redacted deliverable preview; verified role facts; Request a Diagnostic Fit Call.
- **Internal links in:** Logo, all core pages, LinkedIn Featured.
- **Internal links out:** Diagnostic, PA experience case, founder, flagship insight, contact.
- **Schema:** WebPage + Organization/Person inherited.
- **Index now:** Yes.

#### 2. Diagnostic — `/services/diagnostic`

- **Purpose:** Convert consideration into qualified inquiry.
- **Reader / intent:** Buyer comparing advisory, vendor, internal improvement, or staffing options; transactional.
- **Primary question:** “What exactly do we buy, what does it require, and what decision will it enable?”
- **Primary topic:** prior authorization workflow assessment.
- **Related terms:** PA diagnostic, workflow analysis, denial root cause analysis, automation readiness, exception mapping.
- **Title:** Prior Authorization Workflow Diagnostic | 15 Days | TKO
- **Meta:** A fixed-fee 15-business-day diagnostic for one provider-side PA workflow: baseline, root causes, exception map, target workflow, and 90-day plan.
- **H1:** Find the operating causes of prior-authorization delay, rework, denials, and staff dependency.
- **Outline:** Fit trigger → scope/price → questions answered → client inputs → 15-day plan → sample artifact gallery → deliverables → commercial terms → exclusions → FAQ → CTA.
- **Proof / CTA:** Redacted scorecard/workflow/decision-rights excerpt; Request a Diagnostic Fit Call.
- **Internal links in:** Home, healthcare, insights, evidence cases.
- **Internal links out:** Founder, PA evidence case, contact, Sprint.
- **Schema:** Service + Offer; FAQPage may remain but is not a growth dependency.
- **Index now:** Yes.

#### 3. Healthcare / method hub — `/healthcare`

- **Purpose:** Explain the operating model and distinguish TKO from software, staffing, and broad consulting.
- **Reader / intent:** Healthcare operations leader researching how to improve PA performance.
- **Primary question:** “What part of prior authorization does TKO actually address?”
- **Primary topic:** provider-side prior authorization operations.
- **Related terms:** specialty medical group PA workflow, MSO prior authorization, utilization management workflow, administrative burden.
- **Title:** Provider-Side Prior Authorization Operations | TKO Solutions
- **Meta:** A practical operating model for specialty groups and MSOs: intake, evidence, exceptions, decision rights, escalation, measurement, and responsible automation.
- **H1:** Prior authorization performance is an operating-system problem before it is a technology decision.
- **Outline:** Operating boundary → end-to-end workflow → failure modes → measurement model → decision rights → automation readiness → where TKO fits → evidence → CTA.
- **Proof / CTA:** Original end-to-end workflow diagram with evidence boundary; See the Diagnostic.
- **Internal links in:** Home/nav, articles, founder.
- **Internal links out:** Diagnostic, three insights, PA case, contact.
- **Schema:** CollectionPage.
- **Index now:** Yes.

#### 4. Evidence hub — `/selected-work`

- **Purpose:** Let buyers evaluate proof types without confusing experience, internal proof, and client results.
- **Reader / intent:** Diligence-stage buyer, referral partner, recruiter/partner.
- **Primary question:** “What has Todd actually done, and what does it prove?”
- **Primary topic:** prior authorization operations advisor experience.
- **Related terms:** PA workflow design, healthcare transformation, FHIR operations, workflow governance.
- **Title:** Prior Authorization & Healthcare Operations Experience | TKO
- **Meta:** Review Todd Kovalsky’s relevant PA, healthcare transformation, interoperability, and operating-system work, with evidence limits stated clearly.
- **H1:** Evidence relevant to the workflow decision.
- **Outline:** Evidence standard → closest PA experience → healthcare context → internal build proof → method portability (collapsed) → proof needed next → CTA.
- **Proof / CTA:** Artifact thumbnails and evidence labels; See the Diagnostic.
- **Internal links in:** Home, nav, founder, articles.
- **Internal links out:** Each case, Diagnostic, founder, contact.
- **Schema:** CollectionPage + ItemList.
- **Index now:** Yes.

#### 5. PA experience case — `/selected-work/prior-authorization-modernization`

- **Purpose:** Present the closest relevant experience without inventing an outcome.
- **Reader / intent:** Buyer testing domain relevance.
- **Primary question:** “Has Todd worked with the workflow, decisions, and controls I recognize?”
- **Primary topic:** prior authorization workflow design experience.
- **Related terms:** clinical review tiers, PA escalation, exception routing, auditability, human review.
- **Title:** Prior Authorization Workflow Design Experience | TKO
- **Meta:** An anonymized account of PA workflow, review-tier, escalation, exception, and auditability experience—with no unsupported outcome claim.
- **H1:** Prior Authorization Workflow Design Experience
- **Outline:** Context → recognized failure → Todd’s role → artifact/mechanism → decision enabled → evidence → limitation → buyer relevance → CTA.
- **Proof / CTA:** Permissioned redacted artifact or recreated generic example clearly labeled illustrative; See Diagnostic Scope.
- **Internal links in:** Home, evidence hub, Diagnostic, relevant articles.
- **Internal links out:** Diagnostic, founder, operational-quality insight.
- **Schema:** Article.
- **Index now:** Yes, after a concrete artifact is added; keep indexed meanwhile but do not promote heavily.

#### 6. RachelOS proof case — `/selected-work/from-crm-to-operating-system`

- **Purpose:** Prove hands-on implementation and control design, not PA outcomes.
- **Reader / intent:** Buyer asking whether Todd can turn a diagnosis into working operating behavior.
- **Primary question:** “Can he build and govern a working system, not only produce recommendations?”
- **Primary topic:** human-approved operational workflow system.
- **Related terms:** relationship memory, workflow prioritization, approval controls, system health.
- **Title:** RachelOS: Founder-Built Operating System Evidence | TKO
- **Meta:** Inspect a live founder-built system showing durable context, prioritized work, human approval, and operating-health controls—with limits stated.
- **H1:** RachelOS: A live operating environment.
- **Outline:** Operating problem → before state → design decisions → current screens → controls → observed use → limitations → relevance to implementation → CTA.
- **Proof / CTA:** Existing redacted screenshots plus dated validation note; See the Diagnostic.
- **Internal links in:** Home, evidence hub, founder, AI-delivery insight.
- **Internal links out:** Diagnostic, founder, evidence hub.
- **Schema:** Article.
- **Index now:** Yes.

#### 7. Founder — `/founder`

- **Purpose:** Complete human and professional diligence.
- **Reader / intent:** Buyer assessing trust, judgment, and engagement ownership.
- **Primary question:** “Who is Todd, why this problem, and who will actually do the work?”
- **Primary topic:** Todd Kovalsky prior authorization operations advisor.
- **Related terms:** healthcare transformation, interoperability, workflow improvement, principal-led advisory.
- **Title:** Todd Kovalsky | Prior Authorization Operations Advisor
- **Meta:** Todd Kovalsky combines regulated operations, healthcare interoperability, transformation, product, and implementation experience to improve provider-side PA workflows.
- **H1:** The operator behind TKO’s Prior Authorization Performance Diagnostic.
- **Outline:** Headshot + personal thesis → why PA → current role in engagements → selected career evidence → operating principles → proof links → referral language → CTA.
- **Proof / CTA:** Headshot, LinkedIn, selected artifact, verified chronology; Speak with Todd.
- **Internal links in:** All proof and commercial pages.
- **Internal links out:** Diagnostic, evidence, LinkedIn, contact.
- **Schema:** ProfilePage + Person.
- **Index now:** Yes.

#### 8. Flagship educational page — `/insights/prior-authorization-operational-quality-problem`

- **Purpose:** Earn relevance and help buyers reframe the problem.
- **Reader / intent:** Informational; leader researching PA delays, denials, workflow, or automation.
- **Primary question:** “Why are queues and denials symptoms rather than the whole problem?”
- **Primary topic:** prior authorization operational quality.
- **Related terms:** PA process improvement, preventable rework, exception routing, workflow standardization, Gold Card readiness.
- **Title:** Prior Authorization Operational Quality: What to Measure First
- **Meta:** A provider-side guide to measuring PA workflow quality before buying automation: intake, rework, denial causes, exceptions, escalation, and staff dependency.
- **H1:** Prior authorization is an operational-quality problem.
- **Outline:** Executive answer → end-to-end workflow → six quality dimensions → measure definitions → worked example → automation decision gate → checklist → sources → CTA.
- **Proof / CTA:** Original measurement table and sourced regulatory/industry context; Download/use the checklist, then review Diagnostic.
- **Internal links in:** Home, healthcare, related insights, LinkedIn posts.
- **Internal links out:** Diagnostic, healthcare hub, PA case, decision-rights insight.
- **Schema:** Article.
- **Index now:** Yes after removing internal evidence IDs from the reader-facing body and adding public sources.

#### 9. Contact — `/contact`

- **Purpose:** Capture a qualified conversation without creating avoidable friction.
- **Reader / intent:** Conversion.
- **Primary question:** “What happens if I reach out, and what information is safe to share?”
- **Primary topic:** request PA Diagnostic fit call.
- **Title:** Request a Prior Authorization Diagnostic Fit Call | TKO
- **Meta:** Share one provider-side PA workflow under pressure. Todd reviews the request and replies within one business day if the 15-day Diagnostic may fit.
- **H1:** Tell Todd where prior authorization is losing time or capacity.
- **Outline:** What the call does → short form → no-PHI warning → what happens next → privacy link → direct email.
- **Proof / CTA:** Response-time commitment and privacy notice; Submit request.
- **Internal links in:** All CTAs.
- **Internal links out:** Privacy, Diagnostic, founder.
- **Schema:** ContactPage.
- **Index now:** Yes.

### Topic cluster

**Pillar:** `/healthcare` — Provider-side prior authorization operations

| Priority | Supporting asset | Business relevance | Intent | Distinct value / evidence required |
|---|---|---:|---|---|
| 1 | Prior authorization operational-quality guide | Very high | Informational → commercial | Measurement table, workflow diagram, public sources |
| 2 | Prior authorization workflow assessment checklist | Very high | Commercial investigation | Downloadable checklist derived from Diagnostic, not a disguised form |
| 3 | Avoidable denial root-cause framework | High | Problem-aware | Clear definitions, sample taxonomy, no claimed prevalence |
| 4 | PA automation-readiness decision guide | High | Vendor/solution comparison | Decision gate, controls, integration questions |
| 5 | Exception and escalation mapping guide | High | Operational | Original decision-rights matrix |
| 6 | Staff dependency / knowledge concentration in PA | Medium | Informational | Specific PA examples and mitigation steps |
| 7 | Specialty-specific page | Conditional | Commercial | Only after specialty-specific evidence, language, and buyer interviews |
| 8 | Payer/location pages | Do not create now | Low / risky | Would be doorway-like without distinct evidence and service |

### Internal linking

- Every insight links once to `/healthcare`, once to the most relevant sibling insight, and once to `/services/diagnostic`.
- Diagnostic links to the PA experience case, founder, and one educational guide.
- Evidence cases link to the Diagnostic and founder; do not force unrelated cases into every article.
- Homepage links to one flagship insight and two proof units, not the entire library.
- LinkedIn Featured links use tagged URLs to the Diagnostic, flagship guide, and PA evidence case.

### Redirect and canonical plan

- Keep current permanent redirects; spot checks show the major retired namespaces resolve in one hop.
- Do not rename `/services/diagnostic` merely for a longer keyword URL. The title, H1, copy, and internal anchors can carry specificity without another migration.
- If “Results” is renamed to “Evidence,” change labels only; keep `/selected-work`.
- Canonical each page to itself. Keep query/UTM variations canonicalized to the clean route.
- Do not index `/tif`, previews, drafts, generated derivative pages, search/filter states, or internal proof consoles.

---

## 6. TIF multichannel content operating model

### TIF’s market-readiness job

TIF should not be judged by how many drafts it can produce. It should be judged by whether it can reliably support this loop:

```text
Approved evidence and public sources
→ one distinct buyer question
→ one canonical site asset
→ exact approved AssetVersion
→ LinkedIn package
→ Instagram package
→ Facebook package
→ Todd’s manual review and publication
→ tagged visit / conversation / opportunity observation
```

The canonical site asset is the durable source. Social posts are distribution and conversation surfaces, not substitutes for the asset.

### Asset types and publishing rules

| Asset | Job | Indexing rule | Evidence rule | Social derivatives |
|---|---|---|---|---|
| Use-case page | Connect a specific buyer, trigger, decision, and offer | Index only when materially distinct | Real experience/mechanism or clearly labeled method | Buyer/problem posts, artifact carousel, referral-language post |
| Scenario page | Teach through a realistic situation | Index only if it answers a distinct search/buyer question | Label **illustrative scenario** unless it is a permissioned case | Story post, carousel, short narrated video |
| White paper / executive guide | Establish depth and create a sales follow-up asset | Publish an HTML canonical page; offer PDF as a companion | Public sources + original framework/artifact | LinkedIn document, IG carousel, FB executive summary |
| Case/evidence page | Support diligence | Index when proof and boundary are concrete | Source, permission, role, mechanism, limits | Artifact note, evidence-boundary post |
| FAQ/checklist | Resolve objections or enable action | Embed in the strongest relevant page unless independently substantial | Expert review and current sources | Checklist carousel, short text series |
| Insight/article | Answer one educational question | Index when distinct and useful | Public sources and/or admitted experience | POV post, quote card, discussion prompt |

Do not create separate pages for LinkedIn, Instagram, or Facebook copy. All channel packages point to the canonical site asset with approved UTMs.

### Channel roles

#### LinkedIn — primary B2B authority and relationship channel

- Todd’s main publishing surface.
- Best for operator judgment, evidence notes, diagrams, checklists, and referral conversations.
- Default cadence: two posts per week.
- Primary destinations: Diagnostic, guide, evidence case, founder.

#### Instagram — visual proof and human familiarity

- Secondary channel. Use when the source asset has a useful visual, checklist, diagram, or founder story.
- Default cadence: one carousel per week or every other week; optional short video only when Todd is comfortable speaking naturally.
- Do not paste LinkedIn text into captions. Lead with a visual question, keep the caption shorter, and use the profile link or a clearly identified link destination.
- Prioritize carousels such as “five questions before PA automation,” workflow stages, and decision-rights diagrams.

#### Facebook — network/referral reinforcement

- Secondary channel for existing personal and professional relationships.
- Default cadence: one post per week, often a shorter founder-led narrative with a direct link.
- Use plain language and explain why the topic matters to practice leaders; avoid corporate copy.
- A TKO company page is optional. Todd’s personal network is more valuable initially if employer rules permit.

### One-source, three-channel example

**Canonical asset:** “Prior Authorization Operational Quality: What to Measure First”

- **LinkedIn:** 700–1,100 character operating argument ending in one diagnostic question.
- **Instagram:** 7-slide carousel: symptom → six measures → automation gate → guide CTA.
- **Facebook:** 150–300 word founder note explaining why a queue does not reveal the first preventable delay, linking to the guide.
- **Sales follow-up:** direct link to the same guide with no generic newsletter detour.

Each derivative records:

- `sourceAssetId`
- `sourceVersionId`
- destination URL
- editorial track
- platform
- hook
- CTA stage
- UTM
- claim/permission boundary
- reviewer
- approval date
- manual publication URL/date
- observed outcome

### Required TIF improvements before scaled use

1. **Use the persisted Asset/AssetVersion path for TKO.** Do not rely on the stateless compose API as the source of publish-ready Todd content.
2. **Make voice operational.** Todd’s voice label currently does not change output. Create a short approved voice corpus and a human evaluation checklist; do not pretend a label is voice fidelity.
3. **Bind every derivative to an exact approved source version.**
4. **Require destination URL and UTM before approval.**
5. **Require claim and confidentiality checks before channel generation.**
6. **Add a manual publication/outcome record before building automated publishing.**
7. **Generate platform-specific structures, not copied text with a different label.**
8. **Keep Todd as final reviewer and publisher.** No autonomous posting, commenting, messaging, or engagement.

### Todd/Cognizant/UnitedHealthcare content firewall

TIF must treat the following as disallowed source material unless written authorization is attached:

- UnitedHealthcare or Cognizant client names in connection with the current project.
- Client metrics, workflows, architecture, screenshots, artifacts, meeting notes, prompts, emails, or internal terminology.
- Problems or scenarios learned from the project, even when names are removed, if the underlying facts remain identifiable or confidential.
- Employer/client logos presented as customers or endorsements.
- Claims that Todd produced an outcome for the current client.

Allowed source classes:

- Public government/industry sources with citations.
- Todd’s verified, approved career-level experience stated at an appropriately general level.
- TKO-owned methods created independently.
- RachelOS/TIF internal proof with its non-healthcare limits.
- Permissioned former-client evidence.
- Clearly labeled illustrative scenarios composed from public/common patterns rather than current-client facts.

### Sustainable production cadence

Every two weeks:

- 1 canonical or materially upgraded site asset.
- 4 LinkedIn drafts, of which Todd publishes 2 per week.
- 1–2 Instagram carousels.
- 1–2 Facebook posts.
- 1 sales-follow-up excerpt.

This is a ceiling, not a quota. If the canonical asset is weak or evidence is missing, TIF should stop at a brief and surface the gap instead of generating channel volume.

---

## 7. Technical indexing and monitoring checklist

### Before requesting indexing

- [ ] Production title, meta description, canonical, H1, OG image, and schema match the approved position.
- [ ] No public route emits `noindex`.
- [ ] `robots.txt` continues to allow public routes and disallow `/tif`.
- [ ] Sitemap contains only canonical 200 URLs.
- [ ] Sitemap last-modified dates are accurate or omitted.
- [ ] All retired URLs redirect directly to the final canonical destination.
- [ ] Public content and primary internal links appear in server-rendered HTML.
- [ ] Navigation and footer do not link to redirects.
- [ ] Contact form persistence, notification, reconciliation, and success/error journeys are tested in production.
- [ ] Privacy notice is linked at the form.
- [ ] Search Console and Bing verification are present.
- [ ] Analytics and conversion events are verified without PII/PHI/free text.
- [ ] Broken-link scan returns no material internal errors.
- [ ] Structured-data validation has no blocking errors.
- [ ] Mobile and keyboard paths pass.

### Search Console process

1. Verify a Domain property for `tko.solutions` through DNS.
2. Submit `https://tko.solutions/sitemap.xml`.
3. Inspect Home, Diagnostic, Healthcare, PA evidence case, flagship insight, Founder, and Contact.
4. Request indexing only after final content and canonical validation.
5. Record inspection date, crawl result, selected canonical, rendered screenshot, and last crawl in the launch log.
6. Review Page Indexing and Performance weekly for the first 8 weeks, then monthly.

### Diagnose indexing states

| GSC state | Check | Likely response |
|---|---|---|
| Discovered – currently not indexed | Sitemap freshness, internal-link depth, server response, content distinctiveness | Improve internal links and page value; do not resubmit daily |
| Crawled – currently not indexed | Duplicate/thesis overlap, thin proof, soft-404 signals, canonical | Consolidate overlap or add original evidence/tool |
| Duplicate without user-selected canonical | Canonical, redirects, parameter links, internal anchors | Make self-canonical and internal links consistent |
| Alternate page with proper canonical | Confirm intentional duplicate/UTM behavior | No action if expected |
| Google chose different canonical | Compare content and link signals between candidates | Consolidate or strengthen chosen canonical signals |
| Blocked by robots/noindex | Inspect live HTML and robots | Remove only if page is intended public |
| Rendering problem | Compare rendered HTML/screenshot with raw HTML; inspect console/resources | Ensure critical content/links are server-rendered |

Use URL Inspection for individual pages, Page Indexing for patterns, Crawl Stats for server behavior, and Performance for query/page evidence. Do not infer indexation from a single `site:` search alone.

---

## 8. UX and conversion recommendations

1. **Preserve one primary action:** Request a Diagnostic Fit Call.
2. **Shorten first contact:** Name, business email, organization, role, workflow under pressure, timing, consent. Ask sponsor and commercial-readiness questions after initial fit or in step two.
3. **Show one artifact before another disclaimer:** A blurred/redacted scorecard, workflow map, or decision-rights matrix is more persuasive than another paragraph about evidence limitations.
4. **Add a human face:** Headshot and first-person founder opening.
5. **Rename Results to Evidence:** The current cases are credible evidence, but not mostly attributable results.
6. **Replace personal Gmail:** Use a TKO-domain address if deliverability and monitoring are configured.
7. **Publish privacy handling:** Explain business-contact use, processors, retention, and deletion/contact process.
8. **Add lead fail-safe:** Daily reconciliation of new database leads against notifications until alert reliability is proven.
9. **Add spam controls:** Honeypot and rate limit before volume.
10. **Accessibility:** Skip link, `main` id, menu focus return/containment, full keyboard regression, automated accessibility scan, and contrast verification.

### Launch acceptance criteria

- Offer, audience, duration, and outcome are clear above the fold.
- One dominant CTA is used consistently.
- Form persists valid leads, sends/records notification state, and has an operator reconciliation path.
- No PHI or sensitive-data collection is requested.
- Mobile layout and mobile navigation work at 320–430 px.
- All interactive controls work by keyboard with visible focus.
- Headings are hierarchical; controls are labeled; contrast passes WCAG AA.
- Every indexable page has a unique title, description, canonical, and H1.
- Sitemap and robots return 200 and contain the intended directives.
- No accidental public noindex or blocked resource affects core pages.
- Core pages have useful contextual links.
- Structured data reflects visible content and has no material errors.
- Analytics records approved events without PII/PHI/free text.
- GSC is verified and sitemap submitted.
- No material broken links or multi-hop redirects.

---

## 9. 30/60/90-day roadmap

### Days 0–30 — Make the offer observable

- Ratify the expert + Diagnostic position and TIF’s internal role.
- Confirm employer/conflict boundaries.
- Correct LinkedIn website, headline, About, banner, Services, and Featured items.
- Add privacy notice, TKO email, headshot, and lead-notification reconciliation.
- Connect analytics and verify GSC/Bing.
- Shorten or split the contact form.
- Upgrade the flagship operational-quality guide with an original measurement tool and public sources.
- Publish two LinkedIn posts per week and run disciplined commenting.
- Conduct 5–10 buyer/referral conversations; record objections verbatim.

**Exit criteria:** all P0 controls pass; at least five qualified market conversations; source and assisted-touch fields are being captured.

### Days 31–60 — Add proof, not volume

- Build one redacted sample Diagnostic artifact set.
- Secure one permissioned quote, reference, or anonymized evidence package if available.
- Rewrite the PA experience case around artifact/mechanism/decision.
- Publish the assessment checklist and automation-readiness guide.
- Compare Track A expert posts with Track B system-proof posts.
- Review form funnel, source quality, and GSC indexing.
- Refine homepage objections from real conversations.

**Exit criteria:** one stronger proof unit; three distinct useful search assets indexed or inspected; at least one qualified opportunity or clear disqualification evidence.

### Days 61–90 — Validate a repeatable acquisition loop

- Publish only the best-performing content pillar variants.
- Create one sales follow-up sequence using the flagship guide, evidence case, and Diagnostic page.
- Record first-touch, last-touch, self-reported source, and assisted content on every opportunity.
- If a paid engagement occurs, establish baseline definitions and permission protocol before delivery.
- Decide whether the Sprint remains publicly promoted based on Diagnostic conversations.
- Decide whether any TIF measurement persistence is justified by real usage; keep the weekly scorecard manual if not.

**Exit criteria:** measurable path from post/search/referral to qualified call; proof of which content assists opportunities; decision on the next 90 days based on pipeline, not publishing volume.

### Rollback and regression risk

- Roll back content/profile claims immediately if employer, client, or evidence permission is challenged.
- Roll back the analytics adapter—not the event contract—if it captures disallowed data.
- Keep redirects if navigation labels or page copy are reversed.
- Main risks: lost form notifications, unapproved employment/client claims, privacy gaps, content-topic repetition, and mistaking correlated closed deals for TIF-caused revenue.

---

## 10. LinkedIn strategy

### Profile

Because Todd is currently employed by Cognizant on a UnitedHealthcare project, profile changes should be made in two stages.

#### Stage 1 — employment-safe profile alignment

Use while outside-work approval is unresolved:

**Headline**

> Senior Manager, Healthcare Transformation, AI & Analytics | Healthcare Operations, Workflow Modernization & Human-Controlled AI | Founder, TKO Solutions

This improves relevance without publicly soliciting work that may overlap with a current client engagement.

**Banner**

> Better workflows before bigger automation.  
> Healthcare operations · decision rights · human-controlled AI

**About opening**

> I work at the intersection of healthcare operations, workflow modernization, product, governance, and implementation.
>
> Across regulated and relationship-driven environments, I have seen the same failure pattern: the system stores information, but the operating judgment still lives across people, workarounds, handoffs, and exceptions.
>
> My work focuses on making that decision layer visible—what is happening, where work stalls, who owns the next decision, which exceptions require human judgment, and what should be automated only after the workflow is understood.

The remaining About section can use the verified career history and founder-built proof, but should not name UnitedHealthcare or discuss the current project.

#### Stage 2 — commercial TKO profile

Use only after written confirmation that the outside activity and positioning are allowed.

**Headline**

> Prior Authorization Operations Advisor | Helping specialty medical groups and MSOs find the workflow causes of delays, denials, rework, and staff dependency

**Banner**

> Fix the prior-authorization workflow before you fund more automation.  
> 15-business-day Diagnostic · TKO Solutions · tko.solutions

**About**

> Prior authorization problems are often diagnosed too late and too narrowly.
>
> Leaders see backlog, denials, rework, and staff pressure. The operating causes are usually spread across intake, documentation, payer variation, handoffs, exception routing, escalation, and knowledge held by a few experienced people.
>
> I help specialty medical groups, MSOs, and provider-side healthcare operators make that workflow visible before they commit to another vendor, automation program, staffing model, or broad transformation.
>
> TKO’s starting engagement is a principal-led, 15-business-day Prior Authorization Performance Diagnostic for one defined workflow or specialty/payer segment. It produces a measured baseline, current-state workflow and exception map, root-cause analysis, target workflow, and a 90-day plan.
>
> My background spans regulated operations, product ownership, healthcare interoperability, enterprise healthcare transformation, workflow governance, and hands-on system implementation.
>
> I do not sell a PA platform or promise savings before a baseline exists. The work is designed to help leadership decide what to fix, fund, automate, stop, or defer.
>
> If one PA workflow is under pressure, start here: tko.solutions/services/diagnostic

#### Manual profile improvement checklist

Todd can complete these changes manually in approximately 60–90 minutes once the wording is approved:

1. **Contact info:** Replace the current unrelated website with `https://tko.solutions`. Add a TKO-domain email when configured.
2. **Headline:** Use the approved Stage 1 or Stage 2 version. Do not leave the headline as only an employer/title label.
3. **Banner:** Upload a restrained 1584 × 396 banner with one message and the site URL. Do not use employer or client logos.
4. **Profile photo:** Use a current, well-lit professional headshot consistent with the site.
5. **About:** Replace the broad generalist opening with the approved text. Put the buyer/problem or operating thesis in the first two visible lines.
6. **Featured:** Pin the Diagnostic, flagship guide, PA evidence page, and RachelOS proof in that order. Remove old articles that reinforce lending, real estate marketing, or unrelated service categories from the first visible set.
7. **Experience — Cognizant:** Keep the verified employer/title. Describe healthcare transformation, workflow, governance, and AI/analytics at a general level. Do not name the client or project.
8. **Experience — TKO Solutions:** Add the focused founder role, public offer, delivery boundary, and link. Avoid implying Cognizant sponsorship.
9. **Services:** Keep only services Todd is actually allowed and prepared to sell. Prefer Healthcare Consulting, Management Consulting, Change Management, Program Management, and IT/Technology Consulting if those are the closest available categories. Remove SaaS Development, Application Development, Cloud Application Development, Executive Coaching, and other categories that dilute the offer unless they remain real businesses.
10. **Recommendations:** Request 3–5 recommendations from former colleagues or approved contacts who can speak to workflow diagnosis, requirements clarity, cross-functional judgment, documentation, governance, and execution. Do not request recommendations from current UnitedHealthcare stakeholders without written approval.
11. **Skills:** Move Healthcare Consulting, Healthcare Operations, Process Improvement, Product Strategy, Program Management, Change Management, FHIR/Interoperability, and AI Governance toward the top where accurate.
12. **Public activity:** For the next 8–12 posts, stay within the new narrative. Do not alternate PA content with unrelated PE, lending, real estate, or generic AI takes.

#### Experience entry for TKO Solutions

**Title**

> Founder & Principal | Healthcare Workflow and Prior Authorization Operations

**Description**

> TKO Solutions helps provider-side healthcare leaders understand where prior-authorization workflows are losing time, capacity, and consistency before they commit to more automation, staffing, or vendor spend.
>
> Starting engagement: a principal-led, 15-business-day Prior Authorization Performance Diagnostic for one defined workflow or specialty/payer segment.
>
> Outputs include a measured baseline, current-state workflow and exception map, root-cause analysis, target workflow, decision-rights and escalation gaps, and a 90-day improvement plan.
>
> TKO does not provide clinical decision-making, managed PA staffing, or a software platform, and does not promise operational outcomes before a baseline exists.

#### Recommendation request template

> I’m tightening my LinkedIn profile around healthcare workflow modernization and the operating work I’m best at. If you’re comfortable, would you write a short recommendation about our work together—specifically how I clarified a complex workflow, translated across teams, improved decision visibility, or turned requirements into executable work? Please avoid any confidential client details or outcome claims you cannot verify.

#### Featured-item captions

- **Diagnostic:** “The fixed-fee starting engagement: one workflow, 15 business days, measured baseline and 90-day plan.”
- **Operational-quality guide:** “What to measure before buying more PA automation.”
- **PA experience:** “Relevant workflow, review-tier, escalation, and auditability experience—with the evidence boundary stated.”
- **RachelOS proof:** “Founder-built evidence of durable context, prioritized work, human approval, and operating controls. Not healthcare outcome proof.”

### Revenue-first LinkedIn routine

Content should make warm conversations easier; it should not consume the time needed to create them.

Each week:

- Publish two approved posts.
- Leave 9–15 substantive comments across three days.
- Send 5 manual, personalized messages to former colleagues, referral partners, specialty-group/MSO operators, or healthcare advisors with whom Todd has a legitimate relationship.
- Ask for 1–2 introductions using the referral language on the founder page.
- Follow up with anyone who visited, commented meaningfully, or asked a relevant question.
- Record conversations and assisted content in the weekly scorecard.

Suggested warm message:

> I’ve narrowed TKO around a problem I know well: provider-side prior-authorization workflows where delay, rework, denials, or staff dependency are forcing a technology or operating decision. I’m not selling software; the starting work is a 15-day Diagnostic of one workflow. I’d value your reaction to the position, and if someone in your network is actively dealing with that problem, an introduction would be useful. Here is the one-page scope: [tagged Diagnostic URL]

Do not send this to current UnitedHealthcare stakeholders, use Cognizant contact lists, or imply that Todd is contacting them in his employer role.

**Featured**

1. Diagnostic page.
2. Flagship operational-quality guide.
3. PA workflow experience case.
4. RachelOS live operating proof, labeled as non-healthcare implementation evidence.

Remove the unrelated website and broad Services categories that are not actively sold.

### Editorial tracks

#### Track A — Todd’s expertise

Demonstrate how he diagnoses, sequences, and governs workflow improvement:

- Workflow before automation.
- Decision rights and exception routing.
- Measurement and denial-learning.
- Human approval, auditability, and implementation control.
- Lessons from regulated operations and healthcare transformation.

#### Track B — Evidence the system works

Demonstrate mechanisms and observations without claiming unsupported causation:

- A redacted artifact and the decision it supports.
- Before/after **visibility or process** observations, not invented financial outcomes.
- RachelOS mechanisms: durable context, prioritization, approval, operating health.
- TIF production lineage: evidence source → approved asset version → channel derivative.
- Pipeline/deal observations only when tagged to source/touch and bounded by permission.

### Content pillars

| Pillar | Audience | Purpose |
|---|---|---|
| PA operating quality | COO, operations, revenue cycle, patient access | Reframe symptoms into measurable workflow causes |
| Decision rights and exceptions | Operations, clinical/UM, transformation | Show method and judgment |
| Automation readiness | CIO, product, operations, vendor-selection teams | Differentiate from technology-first sellers |
| Founder-built operating proof | Executive buyers and referral partners | Prove implementation/control capability |
| Evidence and measurement | Sponsors and finance-minded buyers | Build trust through claim discipline |

### Founder narrative

Todd’s useful story is not “I have done many kinds of work.” It is:

> For more than 20 years, I have worked at the seams where systems of record stop and operating judgment begins—exceptions, handoffs, controls, decisions, and adoption. Prior authorization concentrates those problems in one expensive workflow.

### Build-in-public narrative

> I am building the evidence discipline I want clients to use: every public claim has a source, boundary, version, approval, and observed outcome. The system can help produce assets; it cannot grant permission, create proof, or decide causation.

### Proof library rules

Every proof item records:

- Claim.
- Proof type: verified career / client-approved / anonymized experience / internal live system / method example.
- Source and date.
- Public permission owner and status.
- Baseline, post-period, definitions, numerator/denominator when quantitative.
- Confounders.
- Causal language allowed: caused / contributed / associated / observed after / mechanism only.
- Client/deal confidentiality rule.
- Approved destination and expiration/review date.

Do not publish a closed deal as TIF proof unless the record shows the approved asset/version, distribution touch, lead identity mapping, opportunity timing, and a defensible role in the journey. Otherwise state only that the deal occurred during the period.

### Cadence

- Two original posts per week.
- One optional document/carousel every other week, only when based on a real artifact.
- 15–20 minutes of relevant commenting on three weekdays.
- One monthly evidence review and one monthly performance review.
- No automated comments, messages, likes, or engagement pods.

### Ten post concepts

1. The PA queue is the symptom; the first preventable delay happens earlier.
2. Five questions to ask before buying PA automation.
3. A denial reason is not a root cause.
4. What one experienced PA specialist knows that the workflow does not.
5. The first three days of a PA Diagnostic.
6. What a vendor dashboard cannot see before intake reaches the platform.
7. Redacted decision-rights map: routine, exception, clinical, escalation.
8. RachelOS lesson: why storing context is different from producing a next action.
9. Evidence note: what TKO can prove today and what it cannot.
10. A 90-day pilot should select 2–4 measures, not promise every outcome.

### Recurring formats

1. **Operating teardown:** symptom → hidden workflow → diagnostic questions → decision.
2. **Artifact note:** one redacted visual → what it shows → what it does not show → how it is used.
3. **Field rule:** one strong principle → counterexample → practical checklist.

### Commenting and relationship routine

- Build a list of 30–40 provider operations, revenue-cycle, patient-access, specialty-group, MSO, and healthcare-transformation leaders.
- On Monday, Wednesday, and Friday, comment on 3–5 relevant posts where Todd has direct experience.
- Add a mechanism, question, or tradeoff; do not summarize the post or pitch TKO.
- After repeated relevant interaction, connect with a short contextual note. Do not send an offer immediately.
- Record only meaningful target-buyer interactions in the scorecard.

### Ethical amplification

- Employees/friends may share only when the topic is genuinely relevant.
- Give them the source post and one optional factual context line, not a copied comment.
- No coordinated like/comment timing, engagement pods, fake accounts, or scripted praise.
- Never ask Cognizant colleagues or clients to imply employer/client endorsement.

### CTA ladder

- **Awareness:** “What part of the workflow is hardest to see?”
- **Consideration:** “I put the five diagnostic questions in the guide.”
- **Conversion:** “If one provider-side PA workflow is under pressure, review the 15-day Diagnostic.”

### Controlled experiments

| Experiment | Hold constant | Change | Learn |
|---|---|---|---|
| Hook | Topic, post body, day | Contrarian statement vs operating observation | Which earns target-buyer dwell/comments, not generic reactions |
| Format | Topic and CTA | Text vs single artifact image vs document | Which produces saves, profile views, and site visits |
| Track | Cadence and format | Expert-led vs system-proof | Which assists qualified conversations |
| CTA | Same post class | Question vs guide vs Diagnostic | Where the audience is in the journey |
| Timing | Same weekday/topic class | Morning vs afternoon | Whether timing materially changes qualified reach |

Run at least four comparable posts before drawing a conclusion. Do not optimize from one viral or weak post.

### 30-day calendar

| Day | Action |
|---:|---|
| 1 | Update profile and Featured; record baseline followers, views, and existing audience mix |
| 2 | Publish Post 1: queue is the symptom (Track A) |
| 3 | Comment on five target-buyer posts; record recurring language |
| 4 | Draft artifact for decision-rights post |
| 5 | Publish Post 2: RachelOS visibility vs action (Track B) |
| 6 | Reply thoughtfully; no new post |
| 7 | Weekly scorecard and qualitative review |
| 8 | Publish Post 3: five questions before PA automation (Track A) |
| 9 | Commenting routine |
| 10 | Turn Post 3 into a checklist section on the site |
| 11 | Publish Post 4: what the evidence does and does not prove (Track B) |
| 12 | Follow up with relevant commenters, without pitching |
| 13 | No post; collect three buyer objections |
| 14 | Weekly scorecard; compare Track A/B rates |
| 15 | Publish Post 5: first three days of a Diagnostic (Track A) |
| 16 | Commenting routine |
| 17 | Draft one-page artifact carousel |
| 18 | Publish Post 6: redacted artifact note (Track B) |
| 19 | Reply and record saves/profile views/site visits |
| 20 | No post; one warm referral outreach using the flagship guide |
| 21 | Weekly scorecard; adjust one variable only |
| 22 | Publish Post 7: denial reason vs root cause (Track A) |
| 23 | Commenting routine |
| 24 | Repurpose flagship guide into three short hooks |
| 25 | Publish Post 8: observed pipeline evidence with explicit attribution boundary, only if data is approved (Track B) |
| 26 | If evidence is not approved, publish a measurement-method post instead |
| 27 | Relationship follow-up with people who engaged repeatedly |
| 28 | Weekly scorecard and content-assisted opportunity review |
| 29 | Publish Post 9: 2–4 measures for a 90-day pilot (Track A) |
| 30 | Monthly review: winners, losers, target-buyer comments, assisted conversations, next-month hypothesis |

### 30-day multichannel companion schedule

TIF should prepare these from the same approved source versions; Todd publishes manually:

| Week | Instagram | Facebook | Canonical site destination |
|---|---|---|---|
| 1 | 7-slide “five signs the PA queue is only the symptom” carousel | Founder note: why Todd is narrowing his work around PA workflow | Homepage or Diagnostic |
| 2 | “Five questions before PA automation” carousel | Short workflow-before-automation explanation | Flagship guide |
| 3 | Redacted/illustrative decision-rights diagram with explicit label | Story about what one experienced operator knows that the process does not | Healthcare/method hub |
| 4 | “What the evidence proves / does not prove” carousel | RachelOS founder-built proof note | RachelOS evidence case |

If Instagram or Facebook produces no relevant conversations, referral activity, or engaged site visits after two controlled months, reduce frequency. LinkedIn and direct relationship work remain primary.

### Five drafted posts

#### Post 1 — The queue is the symptom

Most prior-authorization improvement starts at the queue.

That is usually too late.

By the time a case is waiting, the expensive part may have already happened:

- the intake was incomplete  
- documentation expectations were unclear  
- a payer-specific exception was missed  
- the case followed the wrong path  
- no one owned the escalation

The queue can tell you that work is stuck.

It cannot tell you where the case first became likely to stall.

That is the workflow question I would answer before adding staff or buying more automation:

**Where does a request first become incomplete, variable, or dependent on one experienced person?**

Measure that point first. The intervention becomes much easier to choose.

What is the earliest preventable delay in your current PA workflow?

#### Post 2 — A denial reason is not a root cause

“Missing documentation” is a denial reason.

It is not yet a root cause.

The operating cause could be:

- the ordering workflow never requested the evidence  
- the requirement changed and standard work did not  
- one specialty follows a different path  
- staff know the rule, but the system does not  
- the case was submitted before the exception was reviewed

If leadership stops at the denial code, the response is usually more training or another checklist.

Sometimes that helps.

Sometimes it preserves the same failure one step upstream.

A useful denial review connects the outcome back to the exact intake, evidence, handoff, exception, and decision point that produced it.

The goal is not to count denials more precisely.

The goal is to stop learning the same lesson case by case.

#### Post 3 — Before buying automation

Before I would recommend prior-authorization automation, I would want five answers:

1. Where does the case first become incomplete or variable?
2. Which exceptions require human or clinical judgment?
3. Who has authority to move, stop, or escalate the case?
4. Which measures are reliable enough to establish a baseline?
5. What happens when the automation is wrong, stale, or unavailable?

If those answers are implicit, automation does not remove the operating model.

It hides it inside a faster path.

That can be useful for routine work.

It can also make the wrong path faster.

The right sequence is not anti-technology:

**measure → clarify → control → automate**

Technology should inherit a workflow the organization can explain.

#### Post 4 — What RachelOS proves

I built RachelOS because a CRM could store activity without answering the daily operating question:

**Who needs attention now, why, and what requires human approval?**

The useful change was not another dashboard.

It was making four things inspectable in the same operating environment:

- durable context  
- prioritized work  
- human approval  
- system health

That is direct evidence that I can design and operate a controlled workflow system.

It is not evidence that the same system improves prior-authorization performance.

Those are different claims.

The transferable lesson is the method: make facts, state, priority, exceptions, and approval visible before expecting technology to improve execution.

Good proof should make the boundary clearer, not blur it.

#### Post 5 — The first three days

The first three days of a prior-authorization Diagnostic should not produce recommendations.

They should produce agreement.

Agreement on:

- the workflow boundary  
- the decision leadership needs to make  
- the sponsor and accountable owner  
- the measures and definitions  
- the evidence that exists  
- the evidence that does not

Without that frame, interviews create competing stories and data creates competing dashboards.

The work may still be interesting.

It will not be decision-ready.

I would rather narrow the scope to one workflow and establish a credible baseline than promise an enterprise answer from inconsistent evidence.

By day three, the question should be precise enough that everyone can recognize what is in scope—and what is not.

---

## 11. Content-to-revenue measurement

### Journey

```text
LinkedIn impression or Google query
→ useful post/page
→ method or evidence page
→ fit-call CTA
→ qualified conversation
→ opportunity
→ closed deal
```

### UTM convention

```text
utm_source=linkedin
utm_medium=organic_social
utm_campaign=pa_authority_2026q3
utm_content=tracka_operating-quality_queue-symptom_text_v1
```

Rules:

- Lowercase; hyphens within values.
- `utm_source`: linkedin, google, referral, email.
- `utm_medium`: organic_social, organic_search, referral, email.
- `utm_campaign`: stable quarterly/business initiative.
- `utm_content`: track + pillar + short slug + format + version.
- Never put names, company names, health information, or deal data in UTMs.

### Conversion events

Retain current safe events and add reporting definitions:

- Page/session: landing, engaged visit, guide view, evidence view.
- CTA: primary/secondary click.
- Form: start, validation error, submit attempt, success.
- Commercial: qualified call scheduled, qualified call held, opportunity created, proposal sent, won/lost.
- Assisted: asset/post touched before opportunity or during sales cycle.

Do not send contact fields or free text to analytics.

### CRM/source fields

- First-touch source / medium / campaign / content.
- Last-touch source / medium / campaign / content.
- Self-reported source.
- Referrer/introducer, with permission.
- First landing page.
- Content touched before call.
- Content used during sales cycle.
- Editorial track: A expert / B system proof.
- Qualified call date and disposition.
- Opportunity stage, value range, probability only if already part of the sales process.
- Win/loss reason.
- Closed date and time-to-close.
- Permission status for public evidence.

### Assisted conversion method

For each opportunity, preserve:

1. First known touch.
2. Last pre-conversion touch.
3. Self-reported source.
4. Every material content touch used by the buyer or seller.
5. Introducer/referral.

Report:

- **Sourced pipeline:** opportunity’s first known source.
- **Influenced pipeline:** opportunity touched the asset before close.
- **Sales-enabled pipeline:** Todd intentionally used the asset in follow-up.

Do not sum these as separate revenue. They are overlapping views of the same opportunities.

### Weekly scorecard

| Layer | Metrics |
|---|---|
| LinkedIn reach | Impressions, profile views, relevant follower growth |
| Quality engagement | Saves, target-buyer comments, target-buyer connection requests |
| Site | Visits, engaged visits, landing pages, evidence/Diagnostic views |
| Intent | CTA clicks, form starts, successful inquiries |
| Qualification | Qualified calls requested, scheduled, held |
| Pipeline | Opportunities, stage movement, value, proposals |
| Revenue | Wins, closed value, time-to-close |
| Assisted | Opportunities touched by Track A vs Track B content |
| Efficiency | Todd hours per post/asset, qualified conversations per hour |

Compare rates and buyer quality, not isolated impressions.

### Track A vs Track B comparison

- Tag every URL/post with `tracka` or `trackb`.
- Compare profile-view rate, save rate, target-buyer comment rate, site click rate, qualified-call rate, and assisted-opportunity count.
- Match format and cadence where possible.
- Review after at least four posts per track.
- A track can be valuable with lower reach if it assists more qualified opportunities.

---

## 12. Risks, assumptions, and unresolved questions

### Risks

- Employer conflict or perceived employer endorsement.
- Overstating anonymous enterprise experience.
- Treating Rachel pipeline/deals as TIF-caused revenue.
- Lost inquiries from unmonitored notification failure.
- Collecting contact data without an adequate privacy notice.
- Publishing repetitive PA/AI articles without new evidence or utility.
- Optimizing LinkedIn for broad reach rather than provider-side buyer relevance.
- Creating specialty/location doorway pages before distinct evidence exists.
- Building TIF measurement infrastructure before a manual pilot proves the required fields.

### Assumptions

- TKO, not TIF, is the market-facing business.
- The primary conversion remains a qualified fit-call request.
- The target remains U.S. provider-side specialty groups/MSOs.
- Todd can allocate approximately 2–3 hours per week to LinkedIn and relationship work.
- No client outcome claim is publishable today.

### Unresolved

- Launch date.
- Employer approval.
- Search Console/analytics status.
- Contact notification configuration.
- Scheduling preference.
- Publishable headshot and domain email.
- Approved pipeline/deal proof.
- First specialty or workflow segment to prioritize after buyer conversations.

---

## 13. The next five actions, in exact order

1. **Ratify the market boundary:** TKO sells the expert + Prior Authorization Performance Diagnostic; TIF remains the internal evidence/asset system.
2. **Close launch-control gaps:** verify form persistence and notification in production, add daily lead reconciliation, publish a privacy notice, and confirm employer/conflict permission.
3. **Align Todd’s LinkedIn:** replace the unrelated website, narrow headline/About/Services/banner, and feature the Diagnostic, flagship guide, and evidence case.
4. **Connect observation:** verify Search Console/Bing, connect the approved analytics destination, submit the sitemap, and test the complete non-sensitive conversion event path.
5. **Run the 30-day proof-led pilot:** publish two posts per week, conduct targeted commenting and referral conversations, preserve first/last/self-reported/assisted source data, and review qualified conversations before creating more pages.

---

## 14. Codex implementation package

### Objective

Make the TKO market launch observable, trustworthy, and conversion-safe while keeping TIF as the internal evidence-to-asset mechanism.

### Scope estimate

- **Files modified:** approximately 8–10.
- **New files:** 1–3 (privacy page, optional proof data/asset).
- **New directories:** 0–1.
- **Migrations:** 0 for launch.
- **Schema changes:** none for launch.
- **New services:** no new application service; one approved analytics provider connection may be configured.
- **Operational risk:** medium because contact notification, privacy, analytics, and employer claims affect production trust.

If the scope expands to CRM schema history, publication measurement persistence, or TIF productization, stop and phase it separately.

### Files to modify

- `src/app/layout.tsx`
- `src/app/page.tsx`
- `src/app/founder/page.tsx`
- `src/app/contact/page.tsx`
- `src/components/site/diagnostic-form.tsx`
- `src/components/site/header.tsx`
- `src/components/site/mobile-nav.tsx`
- `src/lib/leads/notify.ts` and/or the smallest operator monitoring surface
- `src/content/insights/prior-authorization-operational-quality-problem.md`
- `src/app/sitemap.ts`
- New privacy route if approved

### Files to avoid

- RachelOS scoring systems, queue ranking, lifecycle derivation, and relationship-state derivation.
- TIF Evidence/Opportunity/Asset core architecture unless a separate approved task requires it.
- Prisma schema and migrations during launch-control work.
- Unrelated modified files currently in the worktree.
- Existing redirect map except for a verified broken or multi-hop route.

### Implementation steps

1. Confirm owner decisions and approved profile/claim language.
2. Add privacy notice and link it from the form/footer.
3. Add lead-notification reconciliation/monitoring and production test procedure.
4. Shorten or split the contact form while preserving the no-PHI warning and safe event payload.
5. Add headshot and revise founder opening.
6. Adjust navigation labels/order without changing canonical routes.
7. Add skip link and mobile focus management.
8. Connect approved analytics and verification variables.
9. Upgrade the flagship guide with a public-source list and original diagnostic tool.
10. Validate build, tests, routes, redirects, metadata, form, events, accessibility, mobile layout, sitemap, and live production only after explicit deployment approval.

### Test plan

- Unit tests for lead notification/reconciliation and form behavior.
- Existing full test and lint suites.
- Production build.
- Desktop/mobile browser QA for Home, Diagnostic, Founder, Evidence, Guide, Contact.
- Keyboard-only navigation and menu focus test.
- Automated accessibility scan plus manual headings/labels/contrast review.
- Valid and invalid local form tests; authorized production canary using non-sensitive test data.
- Confirm database persistence and notification receipt.
- Verify event payload allow-list contains no PII/PHI/free text.
- Crawl all sitemap URLs; validate 200/canonical/H1/title/meta.
- Check retired URLs for one-hop permanent redirects.
- Validate robots, sitemap, schema, OG image, and GSC URL Inspection.

### Acceptance criteria

- All launch acceptance criteria in Section 8 pass.
- No unsupported claim or unapproved employer/client implication is published.
- Lead loss is detectable within one business day.
- Profile and site tell one offer story.
- First/last/self-reported/assisted sources are recorded for every qualified conversation.
- No more than the agreed two weekly posts are required for the pilot.

### Rollback strategy

- Revert the release artifact if form persistence, accessibility, or routing regresses.
- Disable the analytics adapter if event privacy broadens beyond the allow-list.
- Restore the previous form while keeping the privacy notice and lead reconciliation.
- Remove any disputed claim/profile asset immediately pending permission review.

### Regression risk

- Contact conversion loss from form changes.
- Missing or duplicate notifications.
- Analytics double-firing.
- Focus regression in mobile navigation.
- Sitemap freshness errors.
- Accidental overstatement when shortening claim-boundary copy.
